About Cipher Surgical
Our Mission
We are a British company established in 2010 with the goal of improving the efficiency and safety of minimally invasive surgery through the development and commercialization of products that maintain uncompromised surgical vision.
The OpClear® platform, launched in 2013, protects the laparoscope’s lens from condensation and particulates through an intelligent CO2 flow at its tip and removes visual obstructions with an on demand CO2 and saline lens wash, allowing procedures to continue with minimal disruption.
Cipher Surgical is focused on research and development, investing 35% of expenditure annually. Projects include clinical research to validate the impact of the OpClear platform on patient outcomes. This work enables physicians and hospitals to make evidence-based decisions.
Our goal is to make in-situ lens cleaning the standard of care by scientifically demonstrating its true value to healthcare systems worldwide.
The OpClear® platform, launched in 2013, protects the laparoscope’s lens from condensation and particulates through an intelligent CO2 flow at its tip and removes visual obstructions with an on demand CO2 and saline lens wash, allowing procedures to continue with minimal disruption.
Cipher Surgical is focused on research and development, investing 35% of expenditure annually. Projects include clinical research to validate the impact of the OpClear platform on patient outcomes. This work enables physicians and hospitals to make evidence-based decisions.
Our goal is to make in-situ lens cleaning the standard of care by scientifically demonstrating its true value to healthcare systems worldwide.
Company Timeline
Cipher Surgical established
1st generation OpClear design validated
UK and Europe patents granted
Cipher Surgical awarded ISO 13485 certification
CE mark granted for 1st generation OpClear
Japan patent granted
CE mark granted for 1st generation OpClear
Japan patent granted
First in patient use of OpClear in the UK
Development of 2nd generation OpClear (with intelligent Control Unit and use of saline)
CE Mark granted for the 2nd generation OpClear control unit to provide automated intelligent CO2 flow and saline wash at the tip of the laparoscope
UK clinical evaluations
OpClear receives US regulatory clearance (FDA 510k)
OpClear platform gains Japan regulatory clearance
OpClear platform gains Japan regulatory clearance
MDSAP certificate granted
UK Launch
US Clinical Evaluations
UK Launch
US Clinical Evaluations
Japan clinical evaluations
US logistics established
US logistics established
OpClear receives UKCA certificate
OpClear receives MDR CE Mark
OpClear receives FDA 510k, CE & UKCA clearance for 5mm & paediatric use
OpClear registered in Singapore
OpClear receives FDA 510k, CE & UKCA clearance for 5mm & paediatric use
OpClear registered in Singapore
What do the
experts say?
experts say?
Since I have started using this device... I've gone from pulling the scope out 20-plus times in the course of an operation to zero times as far as needing to clean the lens. It's been an absolute game-changer for me
Mercy Hospital, Carthage, United States
The improved surgical acuity delivered by the OpClear® device significantly reduced the risk of conversion to an open procedure
Royal Bournemouth Hospital, United Kingdom
OpClear® device reduced operative duration
King's College Hospital, London, United Kingdom
Well accepted by theatre staff, excellent support for surgical training
Queen Elizabeth Hospital, Birmingham, United Kingdom
Interested in OpClear?
Call 1 844 OPCLEAR (6725327) or send a message on the form below
